Banapenem

DRUG3 trials

Sponsors

Sihuan Pharmaceutical Holdings Group Ltd.

Conditions

Health, SubjectiveHealthy SubjectMultiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects

Phase 1

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem inClinical Healthy Subjects

CompletedNCT03570970

Sihuan Pharmaceutical Holdings Group Ltd.Healthy Subject

Start: 2016-03-14End: 2016-06-02Updated: 2018-06-27

Benapenem PK Phase Ib Multiple-dose Study

CompletedNCT03578588

Sihuan Pharmaceutical Holdings Group Ltd.Health, Subjective

Start: 2015-12-14End: 2016-01-13Updated: 2018-07-06

Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects

Sihuan Pharmaceutical Holdings Group Ltd.Multiple-dose Tolerability and Pharmacokinetic Studies of Benapenem in Clinical Healthy Subjects

Start: 2019-12-16End: 2020-12-30Target: 20Updated: 2019-12-16

Related Papers

A First-in-Human Safety, Tolerability, and Pharmacokinetics Study of Benapenem in Healthy Chinese Volunteers.

2019-02-2610 citations